| Date | Form | Description | Docs | XBRL | Pages |
| 03/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
17 |
| 02/08/24 | DEF 14A | Definitive proxy statements |
|
19 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
2 | |
| 01/16/24 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
25 | |
| 01/16/24 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
46 |
Latest News & Events
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
Read More...Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...